Nolato AB (FRA:NBF) EBIT: €92.9 Mil (TTM As of Mar. 2026)


FRA:NBF Nolato AB FRA:NBF
82 GF Score
Price €4.47
GF Value €5.00
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nolato AB EBIT?

Nolato AB FRA:NBF +6.95% 82 EBIT is €92.9 Mil as of Mar. 2026. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €5.00 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Nolato AB's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €23.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €92.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nolato AB's annualized ROC % for the quarter that ended in Mar. 2026 was 9.02%. Nolato AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 21.97%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nolato AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.34%.


Nolato AB  (FRA:NBF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nolato AB's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=92.84 * ( 1 - 21.98% )/( (743.132 + 862.846)/ 2 )
=72.433768/802.989
=9.02 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Nolato AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=92.84/( ( (308.85 + max(103.101, 0)) + (324.844 + max(108.344, 0)) )/ 2 )
=92.84/( ( 411.951 + 433.188 )/ 2 )
=92.84/422.5695
=21.97 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(147.027 + 99.795 + 19.021) - (65.519 + 0 + 97.223)
=103.101

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(163.582 + 102.959 + 63.038) - (0 + 0 + 221.235)
=108.344

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nolato AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=92.855/1265.258
=7.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nolato AB EBIT Related Terms


Nolato AB EBIT Historical Data

* Premium members only.

The historical data trend for Nolato AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nolato AB EBIT Chart

Nolato AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.50 84.69 60.16 78.94 94.56

Nolato AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.74 24.24 24.73 20.68 23.21

FRA:NBF vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Nolato AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nolato AB EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nolato AB's EV-to-EBIT falls into.


FRA:NBF
82GF Score
Nolato AB FRA:NBF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nolato AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €92.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €92.9 Mil mean?
Nolato AB (FRA:NBF) has a EBIT of €92.9 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nolato AB.
Is Nolato AB's EBIT too high?
Nolato AB's current EBIT is €92.9 Mil. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's EBIT compare to ABT and SYK?
Nolato AB's EBIT of €92.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nolato AB. Nolato AB's current EBIT is €92.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.00, compared to a current price of €4.47 — trading 10.7% below its estimated fair value. The current EBIT is €92.9 Mil. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current EBIT is €92.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nolato AB (FRA:NBF) Overvalued in 2026?

Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued. The current stock price of €4.47 is trading 10.7% below its estimated GF Value™ of €5.00. GuruFocus considers Nolato AB to be Modestly Undervalued.

Key valuation signals for FRA:NBF:

  • EBIT: €92.9 Mil
  • GF Value™: €5.00 vs. price of €4.47 (10.7% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nolato AB Business Description

Address Nolatovagen 32, Torekov, SWE, SE-269 78
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score

Get the complete analysis for FRA:NBF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.47
Price
€5.00
GF Value